Results 271 to 280 of about 166,108 (310)

Targeting EBV in EBV-associated malignancies

2015
Workshop 3: Virus Discovery and ...
Hui, KF, Chiang, AKS, Yeung, PL
openaire   +1 more source

EBV and the making of lupus

Science Translational Medicine
Epstein-Barr virus–mediated B cell reprogramming may initiate systemic lupus erythematosus (Younis et al. , this issue).
Guy Gorochov, Alexis Mathian
openaire   +2 more sources

EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas

2016
Epstein Barr virus (EBV) is a human gamma herpes virus that establishes latency in B cells after primary infection. EBV generally only causes a mild, self-limiting viral illness but is also associated with several malignancies including posttransplantation lymphoproliferative disorder in the immunosuppressed host as well as Hodgkin and non-Hodgkin ...
Lauren P, McLaughlin, Stephen, Gottschalk, Cliona M, Rooney, Catherine M, Bollard   +3 more
openaire   +2 more sources

EBV Replication Enzymes

2001
The Epstein-Barr virus (EBV) can choose between two alternative life styles. It infects B lymphocytes, transforming them into lymphoblastoid lines and, in contrast to neurotropic herpesviruses such as herpes simplex virus type I that establish latency in nondividing neurons, must maintain its latent genomes in cells that have the potential to divide ...
openaire   +2 more sources

Understanding EBV infection and EBV-associated lymphomas in children

Virology
The Epstein-Barr virus (EBV) infects over 90 % of the human population, often behaving as a harmless passenger in most hosts. However, since 1997, it has been classified as a group 1 carcinogen by the International Agency for Research on Cancer (IARC) due to its causal association with several malignancies. Most studies on EBV primary infection and EBV-
openaire   +3 more sources

ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3

Cancer Letters, 2022
Yu Du, Li-Ping Gong, Jian-Ning Chen
exaly  

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases

Frontiers in Immunology, 2021
Clifford M Snapper
exaly  

Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP/VHL/HIF1α/VEGFA pathway

Cancer Letters, 2022
Yu Du, Li-Ping Gong, Jian-Ning Chen
exaly  

Landscape of EBV-positive gastric cancer

Gastric Cancer, 2021
Motonobu Saito, Koji Kono
exaly  

TO EBV OR NOT TO EBV

Annals of Allergy, Asthma & Immunology
C. Wysocki, C. Haddad
openaire   +1 more source